تولید مواد اولیه داروئی البرز بالک (سهامی خاص)
دبالک | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 17,140 0.12
Close Price: 16,900
Cash Flow
AGM
Interim
2026/04/26 Fiscal Year 2025/12/2112 Month / Audited | 2026/02/18 Fiscal Year 2025/12/2112 Month | ||
|---|---|---|---|
Cash Generated from Operations | 902.7 Billion | 1.307 Trillion | |
Income Taxes Paid | -55.401 Billion | -25.72 Billion | |
Net Cash Flow from Operating Activities | 847.299 Billion | 1.281 Trillion | |
Proceeds from Sale of Property, Plant and Equipment | 14.627 Billion | 304 Million | |
Purchases of Property, Plant and Equipment | -344.157 Billion | -260.8 Billion | |
Cash Paid to Acquire Long-Term Investments | -2 Million | -2 Million | |
Cash Received from Income on Other Investments | 1.273 Billion | 1.273 Billion | |
Net Cash Flow from Investing Activities | -328.259 Billion | -259.225 Billion | |
Net Cash Flow before Financing Activities | 519.04 Billion | 1.022 Trillion | |
دریافت های نقدی حاصل از افزايش سرمایه | 607.35 Billion | 607.35 Billion | |
Purchases of Treasury Shares | -12 Billion | -12 Billion | |
Cash Received from Borrowings | 3.864 Trillion | 3.27 Trillion | |
Repayments of Borrowings (Principal) | -3.565 Trillion | -3.55 Trillion | |
Interest Paid on Borrowings | -651.278 Billion | -294.781 Billion | |
Dividends Paid | -23.774 Billion | -303.944 Billion | |
Net Cash Flow from Financing Activities | 218.567 Billion | -283.813 Billion | |
Net Increase (Decrease) in Cash | 737.607 Billion | 737.876 Billion | |
Cash at Beginning of Period | 130.294 Billion | 130.294 Billion | |
Effect of Exchange Rate Changes | 269 Million | - | |
Cash at End of Period | 130.563 Billion | 130.294 Billion | |
Non-Cash Transactions | 4.783 Trillion | 4.398 Trillion |